[Abstract] TGFβ is a potent cytokine modulating various processes including proliferation, differentiation, ECM synthesis and apoptosis (Siegel and Massague, 2003). Thus in many tissues availability of TGFβ is tightly regulated. TGFβ is secreted as an inactive complex where it is encapsulated by the latency associated protein (LAP), a ligand trap protein, which inhibits TGFβ binding to its receptor and retains TGFβ in the extracellular matrix (ten Dijke and Arthur, 2007) .
5. Then wash the matrix two times with PBS only at room temperature to remove all traces of EDTA.
Note: Minimal traces of EDTA will impair keratinocyte adhesion and function! Thus this washing step is very important if you work with keratinocytes!
6. Overlay the matrix coated wells with 50 µl starving KGM and keep at room temperature, while you prepare the cells, to avoid the drying of the matrix. Starving KGM (total volume) in a 1.5 ml Eppendorf tube.
For the antibody blocking controls (condition c and d) incubate mixed cells with αvβ6
integrin-blocking antibody (20 μg/ml) or TGFβ neutralizing antibody (15 μg/ml) in the 1.5 ml Eppendorf tube for 15 min at room temperature before plating.
4. Remove starving KGM from matrix coated wells and quickly plate all conditions (100 µl total volume).
5. Incubate 96-well plate for 16-24 h in a cell culture incubator (37 °C, 5% CO2).
D. Detection of luciferase activity and data analysis
Note: Procedure mainly follows the manufacturers' protocol which can be downloaded on the Promega web site.
1. Equilibrate BrightGlo reagent to room temperature and add 100 µl to each well after equilibrating the cell containing 96-well plate to room temperature for 5 min. http://www.bio-protocol.org/e1314 
